肾小球膜攻击复合物不能可靠反映狼疮肾炎持续C5激活
该研究回顾性分析57例III、IV、V型狼疮肾炎活检,检测C9、C5b-9、C3c、C3d及CD68。C5b-9几乎均阳性且持续数月到数年,活动期与慢性期无差异;毛细血管壁C5b-9强度与常规治疗无反应显著相关,提示其不能可靠反映持续C5激活。
要点
- C5b-9在狼疮肾炎活检中几乎均阳性,且可持续数月至数年。
- 肾小球C5b-9强度在活动期与慢性期无差异,不能区分持续C5激活。
- 毛细血管壁C5b-9较强与常规治疗无反应显著相关。
核心结论
- C5b-9染色在狼疮肾炎几乎总是存在、消退缓慢,不是持续肾小球C5激活的可靠标志物。
研究设计与样本
- 回顾性分析57例III、IV、V型狼疮肾炎活检的临床与病理数据,染色检测C9、C5b-9、C3c、C3d及CD68。
主要发现
- C9与C5b-9染色高度相关,毛细血管壁r=0.92。
- 除一例活检外,所有活动性和慢性增殖性狼疮肾炎的系膜和/或毛细血管壁均检测到C5b-9;所有V型狼疮肾炎活检的毛细血管壁均检测到C5b-9。
- 肾小管基底膜C5b-9染色强度与肾小管间质损伤标志物相关。
- 毛细血管壁C5b-9染色较强与常规治疗无反应显著相关。
- 肾小球C5b-9染色强度在活动性与慢性病变间无差异,而C3c和CD68染色与活动性病变相关。
临床怎么用
- 不应仅凭肾小球C5b-9染色判断狼疮肾炎是否存在持续C5激活或筛选C5抑制剂获益人群。
局限性
- 回顾性研究,样本量57例活检,结论需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Complement plays an important role in the pathogenesis of lupus nephritis (LN). With the emergence of therapeutic complement inhibition, there is a need to identify patients in whom complement-driven inflammation is a major cause of kidney injury in LN. Clinical and histopathological data were obtained retrospectively from 57 biopsies with class III, IV, and V LN. Biopsies were stained for complement components C9, C5b-9, C3c, and C3d and for the macrophage marker CD68. C9 and C5b-9 staining were highly correlated (r = 0.92 in the capillary wall). C5b-9 staining was detected in the mesangium and/or capillary wall of both active and chronic proliferative LN in all but one biopsy and in the capillary wall of class V LN in all biopsies. C5b-9 staining intensity in the tubular basement membrane correlated with markers of tubulointerstitial damage, and more intense capillary wall C5b-9 staining was significantly associated with nonresponse to conventional treatment. Glomerular C5b-9 staining intensity did not differ between active and chronic disease; in contrast, C3c and CD68 staining were associated with active disease. Evaluation of serial biopsies and comparison of staining in active and chronic LN demonstrated that C5b-9 staining persisted for months to years. These results suggest that C5b-9 staining is almost always present in LN, resolves slowly, and is not a reliable marker of ongoing glomerular C5 activation. This limits the utility of C5b-9 staining to identify patients who are most likely to benefit from C5 inhibition.
引用
- Wilson HR, Medjeral-Thomas NR, Gilmore AC, et al. Glomerular membrane attack complex is not a reliable marker of ongoing C5 activation in lupus nephritis. Kidney Int. 2019. PMID: 30655025. doi:10.1016/j.kint.2018.09.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。